Here is a good read from a post on the Facebook gr
Post# of 56323
Our company is expanding rapidly.
Despite this summer's industry wide decline, and our own PPS being lower than the high of the year, we are still up over 1000% for the year.
Based on what it is reasonable to expect from the increased market awareness that our license will cause on arrival, and the range of activity granted by that license, it could be entirely possible to see an increase of another 1000% in the short term.
This valuation is based primarily on the desperate need of the Canadian market for the MMJ of consistent quality that Cen Biotech is ready to produce.
But that is only one segment of what this company endeavors. We are going to be heavily involved in Hemp production, on a Global scale, and the re-introduction of it's many industrial uses, as well as construction, dietary, and environmental.
This in itself will prove to be revenue generator of immense potential.
Those of us who have continued to do our Due Diligence on what the merger with RXNB brings to the cooperate portfolio, have discovered a multitude of websites that indicate many facets of the medical, pharmaceutical, and supplement markets.
Some of these websites are active, and some are merely place holders, possibly representing future forays into new market segments.
Some of these Placeholder sites seem to indicate preparation for the introduction of products that are still being researched by the leading edge medical professionals on our Board of Directors.
Admittedly such speculations on the future potential of the use of placeholder sites won't do anything for our share value in the short term. However it does serve to indicate the cooperate foresightedness to seek out those people who are working in areas that will benefit from access to our product line.
As for what is affecting our PPS currently, the biggest factor is the apparent stagnation of the Licensing process. as much as the wait has been wearing on our collective patience, it is justified by the previous failure in so many early licensees to be able to produce a clean mold free product.
When our company is finally Licensed, it will create the new industry standard, making it considerably harder for other companies to succeed.
Another issue that effects our PPS is the manipulation of the Market Movers who continuing to accumulate by taking advantage of weak traders who are swayed by the negativity generated by paid detractors. (bashers) who use misdirection to create confusion.
One of the avenues of misdirection is the implication of insider selling by our C.E.O. The simple fact of the matter is, the paltry amount that he would be able to sell, based on the 144's, is an amount that would have, by itself, very little effect on the PPS because of the trading volume. What we don't know is, how much of the stated amount, did he sell, and how much of what he sold, did he end up putting right back into the further progress of the company? Based on the amount of activity we have seem from Bill lately, meeting with government officials in both the Ukraine and Tanzania, it is reasonable to assume, that he has invested in more revenue streams to increase the companies global footprint.
This brings us to the subject of Transparency; Seeing all these pictures of Bill with all these foreign dignitaries is probably as transparent as it would be prudent to be at this time. If he was more open with the extant of these negotiations, it might allow other companies to sneak through the cracks and undermine his efforts.
One of his most transparent moves was showing Dr. Sam on the Ukraine trip, which lets us know that the merger is, for all intents and purposes, a done deal.
An announcement on the details of the merger are probably being withheld until after the license announcement, to be effective in improving total valuation at a time of increased market visibility.
In an effort to be transparent as to the direction the company is taking, last week we saw the pictures from the open house in Lakeshore, that included the one with pink lit shelves.
That picture comes from an established and reputable Bio-therapeutics company in Texas, that represents the highest level of technologies available in cGMP manufacturing.
If an essential component of our business model is to use technologies proven by companies of that caliber, then we will have a significant market advantage. We will be able to consistently produce massive quantities of our product in a rigidly controlled environment.
We will succeed because the world needs safe and high quality medicine without dangerous side-effects.
So in conclusion, don't worry about the current share price, it is in no way representative to the intrinsic value of the company. Do not worry about the unintelligent rantings of an insignificant group of uneducated paid bashers.
Trust your own Due Diligence. Recognize all the potential of the FITX family of companies, and of our esteemed Board of Directors. We are part of something big, and it's only going to get bigger!
Hold your imminently very valuable shares tight. you will be very glad you did!